Global Topical Corticosteroids Market is expected to reach USD 4,440.38 million by 2024 from USD 2,828.36 million in 2016, at a CAGR of 5.8%. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Access Full Report:- http://databridgemarketresearch.com/reports/global-topical-corticosteroids-market/
The global topical corticosteroids market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. The global topical corticosteroids market is dominated by LEO Pharma, followed by Glaxosmithkline Plc and Pfizer Inc. Other players in this market include Merck & Co., Inc., Novartis AG, Sanofi, Actimis Pharmaceuticals, Almirall, S.A., AstraZeneca, Zylera Pharmaceuticals among others holds 18.1% of the global topical corticosteroids market in 2016.
Founded in 1908 and headquartered in Ballerup, Denmark. LEO Pharma is involved in development, manufacturing and marketing of pharmaceutical drugs for dermatologic and thrombotic patients. Leo pharma comprises of two major segments Dermatology and Thrombosis. Dermatology segment is further subdivided into Psoriasis, Actinic keratosis, non-melanoma skin cancer, Eczema, Skin infections and Acne.
LEO Pharma A/S is a wholly owned subsidiary of the LEO Foundation. LEO Pharma also has a range of well-established products in the areas of cardiovascular, antibiotics, coagulation, osteoporosis and renal care. Leo pharma is present in Europe, Middle East, Africa, Asia, North America, Central America, South America and Oceania.
Founded in 1830 and headquartered in Middlesex, United Kingdom. Glaxosmithkline (GSK) is involved in research, development and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. Pharmaceuticals segment has major three categories which includes respiratory, HIV and established products. The major categories of vaccine segment include Infanrix/Pediarix, Hepatitis and Meningitis. Consumer healthcare is subdivided into four major segments Wellness, Oral health, Nutrition and Skin health. Topical corticosteroids are offered in both pharmaceutical medicines and consumer healthcare segment.
GSK operates in more than 150 markets globally and has around 87 manufacturing sites. GSK operates on a global basis, primarily through subsidiary companies ViiV Healthcare, Stiefel Laboratories and others.
Founded in 1942 and headquartered in New York, U.S. Pfizer Inc., is engaged in discovering, developing and, manufacturing of healthcare products. Pfizer Inc., operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). Its therapeutic regions incorporate oncology, antibodies, cardiovascular, metabolic, irritation, immunology, neuroscience, torment, uncommon illnesses and purchaser human services.
The company has a strong geographic presence in more than 40 countries across North America, Latin America, Europe, Eastern Europe, the Middle East, Africa, and Asia-Pacific, with manufacturing units in Europe, the Middle East and Africa, Asia-Pacific, Japan, Latin America, and the U.S. The subsidiaries of the company include Agouron Pharmaceuticals (U.S.), G.D. Searle & Company (U.S.), Innopharma (U.S.), Greenstone (U.S.), Parke-Davis (U.S.), and Pfizer UK.
Asia-Pacific Topical Corticosteroids Market – Industry Trends and Forecast to 2027
Global Topical Corticosteroids Market – Industry Trends - Forecast to 2026
North America Topical Corticosteroids Market – Industry Trends and Forecast to 2027
Europe Topical Corticosteroids Market – Industry Trends and Forecast to 2027